Clinical Research Directory
Browse clinical research sites, groups, and studies.
BMI in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment
Sponsor: University of Valencia
Summary
1. To establish the correlation between the evolution of the body mass index in benign intracranial hypertension and the response to treatments. 2. To establish the BMI at which this disease occurs. 3. To establish how much the BMI must be reduced to cure this disease. 4. To assess the evolution and response to treatments of sick people who DO NOT reduce or even continue to increase their BMI despite treatment with Acetazolamide or a possible CSF diversion
Official title: Evolution of Body Mass Index in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment. Retrospective and Prospective Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
25
Start Date
2024-06-27
Completion Date
2027-04-01
Last Updated
2025-04-08
Healthy Volunteers
No
Interventions
Weight loss without pharmacotherapy
The study will record the weight of the patients with Idiopathic Intracranial Hypertension every three months. It will correlate with the response to the different treatment modalities (weight loss with no other intervention, diuretic drugs (acetazolamide), lumboperitoneal shunt, or ventriculoperitoneal shunt). No medication will be provided to help lose weight.
Locations (1)
Consorcio Hospital General Universitario de Valencia
Valencia, Valencia, Spain